BioSpace News Archive

Press Releases

Luye Pharma Announces U.S. Launch of ERZOFRI® (paliperidone palmitate) Extended-Release Injectable Suspension for the Treatment of Schizophrenia and Schizoaffective Disorder

April 7, 2025
·
11 min read
Press Releases

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 4, 2025

April 7, 2025
·
1 min read
Press Releases

Aptevo Therapeutics Announces the Closing of $2.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

April 7, 2025
·
7 min read
Press Releases

Alumis and ACELYRIN File Joint Definitive Proxy Statement for Proposed Merger

April 7, 2025
·
14 min read
Press Releases

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - April 4, 2025

April 7, 2025
·
4 min read
Press Releases

Rhythm Pharmaceuticals to Announce Topline Results from Pivotal Phase 3 TRANSCEND Trial Evaluating Setmelanotide in Patients with Acquired Hypothalamic Obesity

April 7, 2025
·
8 min read
Press Releases

MaaT Pharma Announces Initiation of Coverage of its Stock by H.C. Wainwright & Co

April 7, 2025
·
2 min read
Press Releases

TREMFYA® (guselkumab) is the first and only IL-23 inhibitor to significantly reduce both the signs and symptoms and the progression of structural damage in adults living with active psoriatic arthritis

April 7, 2025
·
13 min read
Press Releases

Sea Pharmaceuticals Announces Strategic Relationship to Advance Treatments For Patients with CNS Disorders

April 7, 2025
·
10 min read
Press Releases

Oasis Files Shareholder Derivative Lawsuit Against Kobayashi Pharmaceutical Directors

April 7, 2025
·
4 min read